Meeting
2019 ASCO Annual Meeting
Clinical outcomes and genomic analysis in patients with very high-risk clinically localized prostate cancer treated by radical prostatectomy.
Authors
Pedro Isaacsson Velho
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
Pedro Isaacsson Velho , David Lim , Hao Wang , Harsimar B Kaur , Mark Christopher Markowski , Michael Anthony Carducci , Emmanuel S. Antonarakis , Colin C. Pritchard , Tamara L. Lotan , Mario A. Eisenberger
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Prostate) Cancer
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Epidemiology/Outcomes
Citation
J Clin Oncol 37, 2019 (suppl; abstr 5067)
DOI
10.1200/JCO.2019.37.15_suppl.5067
Abstract #
5067
Poster Bd #
179
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
A tale of lineage plasticity: Intense neoadjuvant testosterone lowering therapy in localized prostate cancer (PCa) harboring high-risk genomic signatures.
First Author: Fatima Karzai
Poster
2019 Genitourinary Cancers Symposium
Genomic analysis and clinical outcomes of Primary Gleason Pattern 5 (PG5) prostate cancer (PCa) treated with radical prostatectomy (RP).
First Author: Pedro Isaacsson Velho
Poster
2017 Genitourinary Cancers Symposium
Characterization of circulating tumor cells in patients with localized high risk prostate cancer, post-prostatectomy.
First Author: Terence W. Friedlander
Poster
2015 Genitourinary Cancers Symposium
Validation of the Decipher prostate cancer classifier in intermediate to high-risk men treated with radical prostatectomy but without additional therapy upon PSA rise.
First Author: Ashley Ross